(Q47571060)

4 February 2018

reason for preferred rank

title

Treatment Decision for Stage I Non-seminomatous Germ Cell Tumours Based on the Risk Factor “Vascular Invasion” (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

12 November 2022

Treatment decision for stage I non-seminomatous germ cell tumours based on the risk factor "vascular invasion" (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

0 references

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

12 November 2022

author name string

W. Hoeltl

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

J. Pont

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

D. Kosak

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

N. Honetz

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

M. Marberger

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1737260

12 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1737260

12 November 2022

publication date

1 January 1992

1 reference

4 February 2018

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-410X.1992.tb15465.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.1992.tb15465.x/fullpdf

12 November 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

British Journal of Urology

12 November 2022

published in

1 reference

4 February 2018

volume

69

1 reference

4 February 2018

issue

1

1 reference

4 February 2018

page(s)

83-87

1 reference

4 February 2018

Prognostic factors in clinical stage I non-seminomatous germ-cell tumours of the testis

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-410X.1992.TB15465.X

Predicting relapse in stage I non-seminomatous germ cell tumours of the testis

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Clinical stage I nonseminomatous and mixed germ cell tumors of the testis. A clinicopathologic study of 93 patients on a surveillance protocol after orchiectomy alone

12 November 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Evaluation of optimal duration of chemotherapy in favorable-prognosis disseminated germ cell tumors: a Southeastern Cancer Study Group protocol

12 November 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Histopathology in the prediction of relapse of patients with stage I testicular teratoma treated by orchidectomy alone

12 November 2022

4

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Orchidectomy alone in stage I nonseminomatous testicular germ cell tumors

12 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Adjuvant chemotherapy in nonseminomatous testicular tumour stage II.

12 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Testicular cancer: prognostic implications of vascular invasion

12 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Prognostic factors in stage I non-seminomatous germ-cell testicular tumors managed by orchiectomy and surveillance: implications for adjuvant chemotherapy

12 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Changing concepts in the management of clinical stage I nonseminomatous testicular cancer: significance of prognostic factors

12 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Nerve-sparing techniques in retroperitoneal lymphadenectomy in patients with low-stage testicular cancer

12 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Surveillance alone for patients with clinical stage I nonseminomatous germ cell tumors of the testis: preliminary results

12 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Marker Half-Life Analysis as a Prognostic Tool in Testicular Cancer

12 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Orchidectomy alone in testicular stage I non-seminomatous germ-cell tumours

12 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Difficulties of a surveillance study omitting retroperitoneal lymphadenectomy in clinical stage I nonseminomatous germ cell tumors of the testis

12 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

The staging of testicular tumors

12 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Disease relapse in patients with stage I nonseminomatous germ cell tumor of the testis on active surveillance

12 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

Immediate adjuvant chemotherapy versus observation with treatment at relapse in pathological stage II testicular cancer

12 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/J.1464-410X.1992.TB15465.X

12 November 2022

Identifiers

1 reference

4 February 2018

1 reference

4 February 2018